1. Noble M.I., Drake-Holland A.J., Vink H. Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process. QJM. 2008;101(7):513-8.
2. van den Berg B., Vink H. Glycocalyx perturbation: cause or consequence of damage to the vasculature? Am J Physiol Heart Circ Physiol. 2006;290(6):2174-5.
3. Danielli J.F. Capillary permeability and oedema in the perfused frog. J Physiol. 1940;98(1):109-29.
4. Chambers R., Zweifach B.W. Intercellular Cement and Capillary Permeability. Physiol Rev. 1947;27:436-463.
5. Luft J.H. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc. 1966;25:1773-83.
6. Weinbaum S., Tarbell J.M., Damiano E.R. The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng. 2007;9:121-67.
7. Satchell S., Anderson K., Mathieson P. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol. 2004;15:566-74.
8. Vink H., Duling B.R. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am J Physiol Heart Circ Physiol. 2000; 278(1): 285-289.
9. Firth J.A. Endothelial barriers: from hypothetical pores to membrane proteins. J Anat. 2002;200(6): 541-8.
10. Maksimenko A.V., Turashev A.D. Visualization, composition and structure of endothelial glycocalyx. Atherosclerosis and Dyslipidemia. 2011;1:28-40. (In Russ.).
11. Gromova O.A., Torshin I.Y., Sardarian I.S. et al. Prospects for the use of drugs based on orotate magnesium in patients with cardiovascular disease. Effektivnaya Farmakoterapiya. 2013;33:53-62. (In Russ.).
12. Torshin I., Gromova O. Magnesium: fundamental studies and clinical practice. NY: Nova Biomedical Publishers; 2011.
13. Edgell C.J., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Nall Acad Sci USA. 1983; 80: 3734-3737.
14. Edgell C.J., Curiel D.T., Hu P.C., Marr H.S. Efficient gene transfer to human endothelial cells using DNA complexed to adenovirus particles. Biotechniques. 1998;25:264-8.
15. Bauer J., Margolis M., Schreiner C., et al. In vitro model of angiogenesis using a human endotheliumderived permanent cell line: contributions of induced gene expression G-proteins and inlegans. J Cell Physiol. 1982;153:437-49.
16. Anthony E.E. A note on capsule staining. Science. 1931;73:319-20.
17. Pirs E. Histochemistry. Moscow: Lan’; 1962. Russian (Пирс Э. Гистохимия. М.: Лань; 1962).
18. Avtandilov A.G., Dzeranova K.M., Borovaya T.G., Didenko L.V. Effect of magnesium orotate to connective tissue framework and inotropic cardiac function in patients with mitral valve prolapse. Clinico-morphological study. Rational Pharmacotherapy in Cardiology. 2013;9(4):390-7. (In Russ.). (Автандилов А.Г., Дзеранова К.М., Боровая Т.Г., Диденко Л.В. Влияние оротата магния на соединительнотканный каркас и инотропную функцию сердца у пациентов с пролапсом митрального клапана. Клиникоморфологическое исследование. Рациональная Фармакотерапия в Кардиологии. 2013; 9(4): 390-7].
19. National references on maintaining patients with diseases the brachiocephalic arteries. Angiologiya i Sosudistaya Khirurgiya. 2013;19(2) suppl:2-12. (In Russ.).
20. Toroshin I.Y., Gromova O.A. Displaziya of connecting fabric, cell-like biology and molecular mechanisms of influence of a magnesium. Russkiy Meditsinskiy Zhurnal. 2008;(4):263-9. (In Russ.).
21. Torshin I.Y, Gromova O.A., Fedotov L.E., et al. Hemoinformatsionny orotic acid molecule analysis indicates inflammatory, neuroprotective and cardioprotective properties of the ligand of magnesium. Farmateka. 2013;13:95-104. (In Russ.).
22. Mierch J., Crancharov K., Krause G.J. et al. Biological activity and mode of action of some dihydroorotic acid and derivatives. Biomed Biochim Acta. 1987;46(5):307-15.
23. Yarosh A.K. Magnesium and orotic acid two of the most important components for regulating the functions of the nervous and muscular systems. Mezhdunarodnyy Endokrinologicheskiy Zhurnal. 2010;8(32):64-78. (In Russ.) (.